Sanofi's next-generation insulin shows edge over Lantus

[riky]

Sanofi's next-generation insulin shows edge over Lantus

<p><a href="http://news.yahoo.com/sanofis-next-generation-insulin-shows-edge-over-lantus-150410628.html"><img src="http://l1.yimg.com/bt/api/res/1.2/BPLv040LhEQolNhD0VUVqA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-22T150410Z_1_CBRE95L15V200_RTROPTP_2_SANOFI-DIABETES.JPG" width="130" height="86" alt="Employee sorts agent ampoules of the diabetes drug Lantus SoloStar at a manufacturing site of French drugmaker Sanofi in Frankfurt" align="left" title="Employee sorts agent ampoules of the diabetes drug Lantus SoloStar at a manufacturing site of French drugmaker Sanofi in Frankfurt" border="0" /></a>PARIS (Reuters) - An improved version of Sanofi's blockbuster insulin Lantus is better than the older drug at controlling blood sugar lows at night, a common side effect in diabetics treated with insulin, according two late-stage tests published on Saturday. The results for the next-generation treatment, known as U300, could strengthen Sanofi's position as it defends its no. 2 spot in the $43 billion diabetes market from rival drugs. Lantus, a synthetic insulin developed in the 1990s, is currently Sanofi's top-selling product. Last year it grew almost 20 percent to generate 5 billion euros ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login